JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Overall survival for chemotherapy-treated and-untreated patients with... | Download Scientific Diagram
Impact of social disparities on 10 year survival rates in paediatric cancers: a cohort study - The Lancet Regional Health – Americas
Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data | British Journal of Cancer
Trial Outcome Measures | Download Table
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease - Biology of Blood and Marrow Transplantation
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Responses Seen in Advanced Biliary Tract Cancer Treated With CTX-009 Plus Paclitaxel
Progression-Free Survival: Meaningful or Simply Measurable? | Journal of Clinical Oncology
A joint international consensus statement for measuring quality of survival for patients with childhood cancer | Nature Medicine
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and ...
Survival in oncology reimbursement decision-making | CMAR
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis - European Urology Focus
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Overall Survival Results with KISQALI® (ribociclib)
27 Survival analysis | The Epidemiologist R Handbook
Roche | Ever wondered how patient outcomes are measured in clinical trials?
Figure 1, Outcome Measures Framework - Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned - NCBI Bookshelf
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Other efficacy outcome measures by allocated treatment. Kaplan-Meier... | Download Scientific Diagram
Measures of Cancer Survival
